Growing community of inventors

La Jolla, CA, United States of America

Chelsie Macedo

Average Co-Inventor Count = 8.95

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Chelsie MacedoBrendan P Eckelman (5 patents)Chelsie MacedoJohn C Timmer (5 patents)Chelsie MacedoKyle S Jones (3 patents)Chelsie MacedoAmir S Razai (3 patents)Chelsie MacedoRajay A Pandit (3 patents)Chelsie MacedoAbrahim Hussain (3 patents)Chelsie MacedoLucas Rascon (3 patents)Chelsie MacedoMike Kaplan (3 patents)Chelsie MacedoWilliam Crago (2 patents)Chelsie MacedoAndrew Hollands (2 patents)Chelsie MacedoKyle S Jones (2 patents)Chelsie MacedoMilton Ma (2 patents)Chelsie MacedoBryan Becklund (2 patents)Chelsie MacedoQuinn L Deveraux (1 patent)Chelsie MacedoBryan Becklund (1 patent)Chelsie MacedoChelsie Macedo (5 patents)Brendan P EckelmanBrendan P Eckelman (44 patents)John C TimmerJohn C Timmer (41 patents)Kyle S JonesKyle S Jones (15 patents)Amir S RazaiAmir S Razai (12 patents)Rajay A PanditRajay A Pandit (10 patents)Abrahim HussainAbrahim Hussain (10 patents)Lucas RasconLucas Rascon (7 patents)Mike KaplanMike Kaplan (5 patents)William CragoWilliam Crago (7 patents)Andrew HollandsAndrew Hollands (6 patents)Kyle S JonesKyle S Jones (6 patents)Milton MaMilton Ma (4 patents)Bryan BecklundBryan Becklund (4 patents)Quinn L DeverauxQuinn L Deveraux (38 patents)Bryan BecklundBryan Becklund (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Inhibrx, Inc. (3 from 30 patents)

2. Inhibrx Biosciences, Inc. (2 from 11 patents)


5 patents:

1. 12227584 - Multivalent and multispecific OX40-binding fusion proteins

2. 12187804 - Multivalent and multispecific 41BB-binding proteins

3. 11919963 - CD123-binding polypeptides and uses thereof

4. 11566078 - PDL1-binding proteins

5. 11434297 - CD123-binding polypeptides and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…